Register
Login:
Share:
Email Facebook Twitter

Early Stage Investment Opportunities: SyndicateRoom, investing from idea to IPO. Watch here

Share Views Episode 9 - Early Stage Investment Opportunities


Physiomics Share Chat (PYC)



Share Price: 0.0275Bid: 0.025Ask: 0.03Change: 0.00 (0.00%)No Movement on Physiomics
Spread: 0.005Spread as %: 20.00%Open: 0.0275High: 0.0275Low: 0.0275Yesterday’s Close: 0.0275


Share Discussion for Physiomics


Thread View

Please login or register to post a message on Share Chat.

Posts per page:


Chrisatrdg
Posts: 914
Observation
Opinion:Buy
Price:0.0275
Bought at .025 this afternoon
Thu 15:19
I have just Bought 1,250,000 at .025 to try and average down through Barclays Stockbrokers.
 
Utahsaints
Posts: 719
Off Topic
Opinion:No Opinion
Price:0.0275
RE: mm games
Thu 11:42
Your kidding right kaz?
kazimira
Posts: 300
Off Topic
Opinion:No Opinion
Price:0.0275
mm games
Thu 11:26
All todays' "sells" so far are buys.

Dummy run shows offer at .0251, bid at .0243
kazimira
Posts: 300
Off Topic
Opinion:No Opinion
Price:0.0275
sp
Thu 00:00
Expect the sp to pick up from now on, especially on positive news.

Now the element of uncertainty over BioMoti has been removed we have more clarity over what the company is aiming to accomplish. Jim Millen has surely not been sitting on his hands since joining PYC and will have ideas for new contracts with the accent on profitability.

Importantly the Val201 phase 1/11 trial (hormone resistant prostate cancer) is also progressing smoothly with no adverse events, its cohort has been expanded to include less severely ill patients, and it is expected to report as scheduled. PYC will benefit both financially and reputationally from this if it is successful.

http://www.physiomics-plc.com/wp-content/uploads/downloads/2011/09/Collaborative-Agreement-13-September-11.pdf

http://www.lse.co.uk/share-regulatory-news.asp?shareprice=VAL&ArticleCode=66lugy5k&ArticleHeadline=Quarterly_Update_on_Clinical_Developments
Obelix
Posts: 9,762
Off Topic
Opinion:No Opinion
Price:0.0275
Guys
Wed 22:46
We need to stop to help them, We're the ones who lost a fortune here not them... Stop to supporting them, don't Buy any shares from PYC anymore simple!!!!
Obelix
Posts: 9,762
Off Topic
Opinion:No Opinion
Price:0.0275
RE: Pyc
Wed 22:42
Hi Draey, I feel the same Mate. Unfortunately, they are not good enough for us. I'm not here to give you any advice, but try to Sell half and Buy more in VALIRX or SAREUM.
I believe You will recover your loss there in both, but I don't know which one will come first.
Good luck to you Mate.
Obelix
Utahsaints
Posts: 719
Off Topic
Opinion:No Opinion
Price:0.0275
RE: Good or Bad?
Wed 20:51
Latino they had no intention of buying that's the point. The do it to drive up interest and then bang they issue more shares to their mates heavily discounted that will flood market and does nothing but provide working capital and provide a little return to the big seller leaving Pi screwed over
It's a scam
Latino
Posts: 2,240
Off Topic
Opinion:No Opinion
Price:0.0275
Good or Bad?
Wed 17:27
There were many investors here who thought the BioMoti has little revenue and was not a worthwhile aquisition...therefore surely it's good they've withdrawn from this deal than go ahead with it just for the sake of it?
furey
Posts: 1,486
Off Topic
Opinion:No Opinion
Price:0.0275
scam
Wed 16:58
Utahsaints
Posts: 719
Off Topic
Opinion:No Opinion
Price:0.0275
RE: Back to basics
Wed 12:05
Kaz why do you write that there must be some deals in frame where is evidence?




Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk






Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.